MST Trademark

Trademark Overview

On Thursday, August 19, 2021, a trademark application was filed for MST with the United States Patent and Trademark Office. The USPTO has given the MST trademark a serial number of 90892398. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, August 1, 2024. This trademark is owned by VYNE Therapeutics Inc.. The MST trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of topical pharmaceuticals for dermatological use in humans
mst

General Information

Serial Number90892398
Word MarkMST
Filing DateThursday, August 19, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, August 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements

Description of MarkThe mark consists of the stylized letters "MST" below stylized curved shapes inside a shaded square background.
Goods and ServicesDrug delivery agents consisting of compounds that facilitate delivery of a wide range of topical pharmaceuticals for dermatological use in humans

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 7, 2021
Primary Code005
First Use Anywhere DateMonday, November 20, 2023
First Use In Commerce DateMonday, November 20, 2023

Trademark Owner History

Party NameJOURNEY MEDICAL CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSCOTTSDALE, AZ 85258
Party NameJOURNEY MEDICAL CORPORATION
Party Type12 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSCOTTSDALE, AZ 85258
Party NameVYNE PHARMACEUTICALS INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressBRIDGEWATER, NJ 08807
Party NameVYNE Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBridgewater, NJ 08807

Trademark Events

Event DateEvent Description
Friday, February 4, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, August 23, 2021NEW APPLICATION ENTERED
Thursday, October 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 8, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, May 20, 2022ASSIGNED TO EXAMINER
Wednesday, June 1, 2022NON-FINAL ACTION WRITTEN
Wednesday, June 1, 2022NON-FINAL ACTION E-MAILED
Wednesday, June 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 14, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, November 23, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 24, 2023ASSIGNED TO LIE
Wednesday, January 25, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 25, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 6, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 9, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 9, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 9, 2023SOU EXTENSION 1 FILED
Thursday, November 9, 2023SOU EXTENSION 1 GRANTED
Saturday, November 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 12, 2023USE AMENDMENT FILED
Tuesday, December 12, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, December 20, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 20, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, January 18, 2024SU - NON-FINAL ACTION - WRITTEN
Thursday, January 18, 2024NON-FINAL ACTION E-MAILED
Thursday, January 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 1, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, August 1, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, April 18, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, April 18, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, May 9, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

delivery topical pharmaceuticals humans range dermatological facilitate agents consisting compounds